140 related articles for article (PubMed ID: 24280122)
1. The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram.
O'Brien FE; O'Connor RM; Clarke G; Donovan MD; Dinan TG; Griffin BT; Cryan JF
Behav Brain Res; 2014 Mar; 261():17-25. PubMed ID: 24280122
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodents.
O'Brien FE; O'Connor RM; Clarke G; Dinan TG; Griffin BT; Cryan JF
Neuropsychopharmacology; 2013 Oct; 38(11):2209-19. PubMed ID: 23670590
[TBL] [Abstract][Full Text] [Related]
3. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
5. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
[TBL] [Abstract][Full Text] [Related]
6. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
Sánchez C; Kreilgaard M
Pharmacol Biochem Behav; 2004 Feb; 77(2):391-8. PubMed ID: 14751469
[TBL] [Abstract][Full Text] [Related]
7. Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression.
O'Brien FE; Moloney GM; Scott KA; O'Connor RM; Clarke G; Dinan TG; Griffin BT; Cryan JF
Pharmacol Res Perspect; 2015 Dec; 3(6):e00190. PubMed ID: 27022464
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
[TBL] [Abstract][Full Text] [Related]
9. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.
Deltheil T; Tanaka K; Reperant C; Hen R; David DJ; Gardier AM
Int J Neuropsychopharmacol; 2009 Aug; 12(7):905-15. PubMed ID: 19236729
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.
O'Brien FE; Clarke G; Fitzgerald P; Dinan TG; Griffin BT; Cryan JF
Br J Pharmacol; 2012 Jun; 166(4):1333-43. PubMed ID: 22250926
[TBL] [Abstract][Full Text] [Related]
11. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
[TBL] [Abstract][Full Text] [Related]
12. DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests.
Szopa A; Poleszak E; Bogatko K; Wyska E; Wośko S; Doboszewska U; Świąder K; Wlaź A; Dudka J; Wróbel A; Wlaź P; Serefko A
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1361-1371. PubMed ID: 30094458
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
Vijaya Kumar K; Rudra A; Sreedhara MV; Siva Subramani T; Prasad DS; Das ML; Murugesan S; Yadav R; Trivedi RK; Louis JV; Li YW; Bristow LJ; Naidu PS; Vikramadithyan RK
Brain Behav Immun; 2014 Nov; 42():204-11. PubMed ID: 25016199
[TBL] [Abstract][Full Text] [Related]
14. Xiaochaihutang prevents depressive-like behaviour in rodents by enhancing the serotonergic system.
Su GY; Yang JY; Wang F; Xiong ZL; Hou Y; Zhang K; Song C; Ma J; Song SJ; Teng HF; Wu CF
J Pharm Pharmacol; 2014 Jun; 66(6):823-34. PubMed ID: 24359306
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.
Szopa A; Doboszewska U; Herbet M; Wośko S; Wyska E; Świąder K; Serefko A; Korga A; Wlaź A; Wróbel A; Ostrowska M; Terlecka J; Kanadys A; Poleszak E; Dudka J; Wlaź P
Toxicol Appl Pharmacol; 2017 Dec; 337():95-103. PubMed ID: 29107002
[TBL] [Abstract][Full Text] [Related]
16. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
[TBL] [Abstract][Full Text] [Related]
17. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.
Berrocoso E; Mico JA
Int J Neuropsychopharmacol; 2009 Sep; 12(8):1033-44. PubMed ID: 19341511
[TBL] [Abstract][Full Text] [Related]
18. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice.
Peng WH; Lo KL; Lee YH; Hung TH; Lin YC
Life Sci; 2007 Aug; 81(11):933-8. PubMed ID: 17804020
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
[TBL] [Abstract][Full Text] [Related]
20. Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):258-64. PubMed ID: 16488409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
